New Zealand markets closed

BLIS Technologies Limited (BLT.NZ)

NZSE - NZSE Delayed price. Currency in NZD
Add to watchlist
0.01700.0000 (0.00%)
At close: 03:20PM NZDT

BLIS Technologies Limited

442 Moray Place
Public Trust Building Ground Floor
Dunedin 9016
New Zealand
64 3 474 0988
https://www.blis.co.nz

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees45

Key executives

NameTitlePayExercisedYear born
Scott Ogilvie Johnson B.Com., M.B.A.Chief Executive OfficerN/AN/AN/A
Mr. Richard Wingham B.Com., C.A.Chief Financial OfficerN/AN/AN/A
Dr. John David-Francis Hale BSc (Hons), Ph.D.Chief Technology OfficerN/AN/AN/A
Jennifer WalkerChief Revenue OfficerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NZD.

Description

BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company markets two strains of probiotic bacteria, which include BLIS K12, a probiotic supplement to support ear, nose, and throat health of young children, as well as for improving immunity and bad breath; BLIS M18, an oral probiotic to support teeth, gums, and dental health; and BLIS Q24, a probiotic supplement to balance and restore the skin microbiome, restoring the health, clarity, and radiance. It has operations in New Zealand, Asia Pacific, Europe, the Middle East, Africa, and North America. The company was incorporated in 2000 and is based in Dunedin, New Zealand.

Corporate governance

BLIS Technologies Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.